John Kerrigan - IShares MSCI Independent Director
| EEM Etf | USD 43.34 0.45 1.03% |
Mr. John E. Kerrigan is Independent Director of iShares MSCI Emerging Markets. He was a Trustee of the Trust since 2005 and Chairman of the Nominating and Governance Committee of the Trust since 2010. Mr. Kerrigan has served as a Director of iShares, Inc. since 2005, Chairman of the Nominating and Governance Committee of iShares, Inc. since 2010, a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2010 and Chairman of the Nominating and Governance Committee of iShares MSCI Russia Capped Index Fund, Inc. since 2010. Mr. Kerrigan serves as Chief Investment Officer, Santa Clara University since 2002. Mr. Kerrigan was formerly a Managing Director at Merrill Lynch Co., including the following responsibilities Global Manager of Institutional Client Division eCommerce, Global Manager of Technology Specialists Sales and Chair, Performance Measurement, Evaluation Compensation Task Force. Mr. Kerrigan is a Trustee, since 2008, of Sacred Heart Schools, Atherton, CA, and Director, since 1999, of The BASIC Fund
| Age | 60 |
| Tenure | 19 years |
| Web | http://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf |
| Issuer | iShares |
| Inception Date | 2003-04-07 |
| Benchmark | MSCI Emerging Markets Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 18.38 Billion |
| Average Trading Valume | 26.59 Million |
| Asset Type | Equity |
| Category | Broad Equity |
| Focus | Strategy |
| Market Concentration | Emerging Markets |
iShares MSCI Emerging Money Managers
| Robert Silver, Independent Chairman of the Board | ||
| John Kerrigan, Independent Director | ||
| Madhav Rajan, Independent Director | ||
| Cecilia Herbert, Independent Director | ||
| Michael Latham, President Director | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Director | ||
| Edward Baer, Chief Legal Officer, Vice President | ||
| Eilleen Clavere, Secretary | ||
| Scott Radell, Executive Vice President | ||
| George Parker, Independent Director | ||
| John Martinez, Independent Director | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Director | ||
| Ira Shapiro, Vice President |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares MSCI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Operating Margin | 68.07 % | |||
| Current Valuation | 28.15 B | |||
| Shares Outstanding | 752.4 M | |||
| Shares Owned By Insiders | 0.29 % | |||
| Shares Owned By Institutions | 77.52 % | |||
| Price To Earning | 2.98 X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 68.86 X | |||
| Revenue | 532.42 M | |||
| Gross Profit | 341.73 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as iShares MSCI Emerging using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in iShares MSCI Emerging. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the iShares MSCI Emerging information on this page should be used as a complementary analysis to other IShares MSCI's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
The market value of iShares MSCI Emerging is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares MSCI's value that differs from its market value or its book value, called intrinsic value, which is IShares MSCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares MSCI's market value can be influenced by many factors that don't directly affect IShares MSCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares MSCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares MSCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares MSCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.